Diphenhydramine (Benadryl) Misuse Falls Under "Other (or Unknown) Substance Use Disorder"
Diphenhydramine misuse is classified as "Other (or Unknown) Substance Use Disorder" in DSM-5, as it does not fit into the ten specific substance classes explicitly named in the manual. 1
DSM-5 Classification Framework
The DSM-5 consolidated the previous DSM-IV categories of "abuse" and "dependence" into a single diagnosis: Substance Use Disorder, which is then specified by the substance class involved 1. The manual identifies ten specific substance classes:
- Alcohol
- Cannabis
- Hallucinogens
- Inhalants
- Opioids
- Sedatives, hypnotics, or anxiolytics
- Stimulants
- Tobacco
- Caffeine
- Other (or unknown) substances
Why Diphenhydramine Doesn't Fit Standard Categories
Diphenhydramine is an antihistamine with anticholinergic properties 2. While it has sedating effects, it is not classified as a sedative-hypnotic in the pharmaceutical sense. Its mechanism of action—H1 receptor antagonism with secondary antimuscarinic activity—produces deliriant effects at high doses rather than typical sedative-hypnotic effects 3.
The documented cases of diphenhydramine dependence demonstrate classic DSM-5 substance use disorder criteria including:
- Tolerance (escalating doses up to 30 tablets daily) 4
- Withdrawal symptoms (hyperactive delirium, autonomic dysfunction, increased muscle tone) 5
- Continued use despite harm 4, 6
- Craving and loss of control 4
Clinical Implications
When documenting diphenhydramine misuse, code it as "Other (or Unknown) Substance Use Disorder" and specify diphenhydramine in the clinical notes. The severity should be graded as mild (2-3 criteria), moderate (4-5 criteria), or severe (6+ criteria) based on the number of DSM-5 substance use disorder criteria met 1.
Important Clinical Pitfalls:
- Don't overlook over-the-counter medications when taking substance use histories—patients and clinicians often fail to consider OTC drugs as having abuse potential 4
- Screen patients with psychotic disorders more carefully—there appears to be a link between antipsychotic use and diphenhydramine misuse 4
- Recognize withdrawal can be severe and life-threatening, requiring careful medical management with gradual tapering and potentially antipsychotic agents like loxapine 5
- Community pharmacists should monitor for excessive requests, particularly in patients with psychiatric illness or addiction history 4, 6
The substance must be "pharmacologically capable of producing the psychiatric symptoms" per DSM-5 criteria 1, which diphenhydramine clearly is, given its documented ability to produce substantial psychoactive effects including hallucinations, confusion, and dysphoria 3.